Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag in chronic liver disease–related thrombocytopenia before elective procedures
CTR20140710Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of avatrombopag in Thrombocytopenia, sponsored by Eisai Co., Ltd.. Started Sep 2015; status: completed.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on CTR20140710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140710.